Product Information
CARBIDOPA 25 MG TABLET is a generic product labeled by Alvogen Inc., priced at $0.9410 per EA under NDC 47781033201. Its NADAC has been published 432 times since Jul 27, 2016.
Strength
25 mg/1
Manufacturer
Alvogen Inc.NDC
47781033201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
CARBIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA204291On Market Since
1/25/2016
Price Statistics
The NADAC for CARBIDOPA 25 MG TABLET has been published 432 times since Jul 27, 2016, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9410 per EA |
|---|---|
| All-time high | $8.0038 (May 10, 2017) |
| All-time low | $0.6717 (May 22, 2024) |
| Median price | $3.5801 |
| Average price | $3.6173 |
| Largest weekly change | -60.1% (Feb 23, 2022) |
| Weeks tracked | 432 |
| Tracking since | Jul 27, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Carbidopa Tablets, 25 mg market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CARBIDOPA 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA 25 MG TABLET, manufactured by Alvogen Inc., is $0.9410 per EA (NDC 47781033201), effective Oct 30, 2024.
How has the price of CARBIDOPA 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBIDOPA 25 MG TABLET has declined 87.9%. It has been tracked across 432 weekly CMS publications since Jul 27, 2016.
What are the highest and lowest recorded NADAC prices for CARBIDOPA 25 MG TABLET?
Since Jul 27, 2016, the NADAC for CARBIDOPA 25 MG TABLET has ranged from a low of $0.6717 (May 22, 2024) to a high of $8.0038 (May 10, 2017), with a median of $3.5801 per EA.
Are there cheaper alternatives to CARBIDOPA 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBIDOPA 25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CARBIDOPA 25 MG TABLET?
CARBIDOPA 25 MG TABLET (NDC 47781033201) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification